Bacteriophage Endolysins as a Novel Class of Antibacterial Agents

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Experimental biology and medicine

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/153537020623100402PMID 16565432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Holin Protein of Bacteriophage PRD1 Forms a Pore for Small-Molecule and Endolysin Translocation

  2005cited by this paper
• The Recombinant Phage Lysin LysK Has a Broad Spectrum of Lytic Activity against Clinically Relevant Staphylococci, Including Methicillin-Resistant Staphylococcus aureus

  2005cited by this paper
• Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli.

  2005cited by this paper
• Evolving strategies for enzyme engineering.

  2005cited by this paper
• Synergistic Killing of Streptococcus pneumoniae with the Bacteriophage Lytic Enzyme Cpl-1 and Penicillin or Gentamicin Depends on the Level of Penicillin Resistance

  2005cited by this paper
• Disulfide Isomerization After Membrane Release of Its SAR Domain Activates P1 Lysozyme

  2005cited by this paper
• Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.

  2005cited by this paper
• The two-component cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M phage varphiWMY: cloning, sequencing, expression, and mutational analysis in Escherichia coli.

  2005cited by this paper
• Bacteriophage endolysins--current state of research and applications.

  2005influential reference
• Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme

  2005cited by this paper
• Therapeutic Effects of Bacteriophage Cpl-1 Lysin against Streptococcus pneumoniae Endocarditis in Rats

  2005cited by this paper
• Control of bacteriophage T4 tail lysozyme activity during the infection process.

  2005cited by this paper
• Bacteriophage lytic enzymes: novel anti-infectives.

  2005cited by this paper
• The viriosphere, diversity, and genetic exchange within phage communities.

  2005cited by this paper
• Structure and Lytic Activity of a Bacillus anthracis Prophage Endolysin*

  2005cited by this paper
• Expression of bacteriophage phiEa1h lysozyme in Escherichia coli and its activity in growth inhibition of Erwinia amylovora.

  2004cited by this paper
• The Use of Phage Lytic Enzymes to Control Bacterial Infections

  2004cited by this paper
• Multiple roles of T7 RNA polymerase and T7 lysozyme during bacteriophage T7 infection.

  2004cited by this paper
• Vincent Fischetti-following phages for life

  2004cited by this paper
• How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy.

  2004cited by this paper
• Ecology of prokaryotic viruses.

  2004cited by this paper
• China approves first gene therapy

  2004cited by this paper
• Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis

  2004cited by this paper
• The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.

  2004cited by this paper
• Identification of a Broadly Active Phage Lytic Enzyme with Lethal Activity against Antibiotic-Resistant Enterococcus faecalis and Enterococcus faecium

  2004cited by this paper
• Population and evolutionary dynamics of phage therapy

  2004cited by this paper
• Mur-LH, the Broad-Spectrum Endolysin of Lactobacillus helveticus Temperate Bacteriophage φ-0303

  2004cited by this paper
• A signal-arrest-release sequence mediates export and control of the phage P1 endolysin.

  2004cited by this paper
• Phage-Host Interaction: an Ecological Perspective

  2004cited by this paper
• Orphan Drugs of the Future?

  2004cited by this paper
• The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30.

  2004influential reference
• Vincent Fischetti--following phages for life. Interview by Marilynn Larkin.

  2004cited by this paper
• The antibiotic pipeline--challenges, costs, and values.

  2004cited by this paper
• The R gene product of bacteriophage λ is the murein transglycosylase

  2004cited by this paper
• Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

  2004cited by this paper
• Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.

  2003influential reference
• Improved Pharmacokinetics and Reduced Antibody Reactivity of Lysostaphin Conjugated to Polyethylene Glycol

  2003cited by this paper
• Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model

  2003cited by this paper
• Sizing the Holin Lesion with an Endolysin-β-Galactosidase Fusion

  2003cited by this paper
• Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1.

  2003cited by this paper
• Antibacterials: are the new entries enough to deal with the emerging resistance problems?

  2003cited by this paper
• Synergistic Lethal Effect of a Combination of Phage Lytic Enzymes with Different Activities on Penicillin-Sensitive and -Resistant Streptococcus pneumoniae Strains

  2003cited by this paper
• Sizing the holin lesion with an endolysin-beta-galactosidase fusion.

  2003cited by this paper
• Novel Method to Control Pathogenic Bacteria on Human Mucous Membranes

  2003cited by this paper
• Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia

  2003cited by this paper
• The Murein Hydrolase of the Bacteriophage φ3626 Dual Lysis System Is Active against All Tested Clostridium perfringens Strains

  2002cited by this paper
• Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis

  2002cited by this paper
• C‐terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high‐affinity binding to bacterial cell wall carbohydrates

  2002cited by this paper
• Bacteriophage holins: deadly diversity.

  2002cited by this paper
• A bacteriolytic agent that detects and kills Bacillus anthracis

  2002cited by this paper
• Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

  2002cited by this paper
• Molecular analysis of the lysis protein Lys encoded by Lactobacillus plantarum phage phig1e.

  2002cited by this paper
• Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

  2001cited by this paper
• Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase

  2001cited by this paper
• Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram‐negative bacteria

  2001cited by this paper
• Bacteriophage Therapy

  2001cited by this paper
• Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

  2001influential reference
• The Lysis Protein E of φX174 Is a Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis*

  2001cited by this paper
• A Protein Antibiotic in the Phage Qβ Virion: Diversity in Lysis Targets

  2001cited by this paper
• Nasal Carriage as a Source of Staphylococcus aureus Bacteremia

  2001cited by this paper
• Tailoring new enzyme functions by rational redesign.

  2000cited by this paper
• Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.

  2000cited by this paper
• Gene Cloning and Expression and Secretion ofListeria monocytogenes Bacteriophage-Lytic Enzymes inLactococcus lactis

  2000cited by this paper
• The N-Terminal Region of the Oenococcus oeniBacteriophage fOg44 Lysin Behaves as a Bona Fide Signal Peptide inEscherichia coli and as a cis-Inhibitory Element, Preventing Lytic Activity on Oenococcal Cells

  2000cited by this paper
• Phages will out: strategies of host cell lysis.

  2000cited by this paper
• Evidence for a Holin-Like Protein Gene Fully Embedded Out of Frame in the Endolysin Gene of Staphylococcus aureusBacteriophage 187

  1999cited by this paper
• Multiple Enzymatic Activities of the Murein Hydrolase from Staphylococcal Phage φ11

  1999cited by this paper
• The non‐enzymatic microbicidal activity of lysozymes

  1999cited by this paper
• The bacteriology of the nasopharynx in childhood.

  1999cited by this paper
• TRANSFORMATION OF APPLE CULTIVARS WITH T4-LYSOZYME-GENE TO INCREASE FIRE BLIGHT RESISTANCE

  1999cited by this paper
• Nasal colonization by Staphylococcus aureus in active, independent, community seniors.

  1999cited by this paper
• Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity.

  1999cited by this paper
• Cloning and expression of a gene encoding the lytic functions of Bacillus amyloliquefaciens phage: Evidence of an auxiliary lysis system.

  1999cited by this paper
• Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis

  1998cited by this paper
• The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin.

  1998cited by this paper
• Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli

  1997cited by this paper
• Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics.

  1997cited by this paper
• The lytic enzyme of the pneumococcal phage Dp‐1: a chimeric lysin of intergeneric origin

  1997cited by this paper
• Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic

  1997cited by this paper
• The Pneumococcal Cell Wall Degrading Enzymes: A Modular Design to Create New Lysins?

  1997cited by this paper
• Filamentous phage assembly: variation on a protein export theme.

  1997cited by this paper
• Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

  1997cited by this paper
• Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling.

  1996cited by this paper
• Binding and degradation of elastin by the staphylolytic enzyme lysostaphin.

  1995cited by this paper
• Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes

  1995cited by this paper
• Genetic and biochemical characterization of the Lactobacillus delbrueckii subsp. lactis bacteriophage LL-H lysin

  1995cited by this paper
• Enhanced bactericidal action of lysozyme to Escherichia coli by inserting a hydrophobic pentapeptide into its C terminus.

  1994cited by this paper
• The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase.

  1994cited by this paper
• Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora

  1993cited by this paper
• Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal‐clostridial cell wall lytic enzyme

  1993cited by this paper
• Agents that increase the permeability of the outer membrane.

  1992cited by this paper
• Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits.

  1991cited by this paper
• Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes.

  1990cited by this paper
• Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages.

  1988cited by this paper
• Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin

  1987cited by this paper
• The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.

  1986cited by this paper
• The R gene product of bacteriophage lambda is the murein transglycosylase.

  1981cited by this paper
• STUDIES OF L FORMS AND PROTOPLASTS OF GROUP A STREPTOCOCCI

  1959cited by this paper
• The mechanism of lysis by phage studied with defective lysogenic bacteria.

  1958cited by this paper

• Recent Advances in Endolysin Engineering

  2025influential citation
• Outlooks of endolysins with innolysins therapeutic potentials against antimicrobial resistance

  2025influential citation
• Engineering Endolysins for Enhanced Bacteriolytic Activity Using Genetically Encoded Azido-Containing Noncanonical Amino Acids.

  2025cites this paper
• Advances in the application and use of bacteriophages and endolysins to inhibit Staphylococcus aureus contamination in foods

  2025cites this paper
• Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside

  2025cites this paper
• Genomic and functional characterization of a novel temperate Coventryvirus phage infecting Staphylococcus pseudintermedius

  2025cites this paper
• Phage-Encoded Lysis Proteins (Holins and Spanins): Mechanisms and Emerging Applications

  2025cites this paper
• Identification of a novel bacteriophage attachment site into ffs, the 4.5S non-coding RNA component of the signal recognition particle

  2025cites this paper
• Bacteria- and Phage-Derived Proteins in Phage Infection.

  2025cites this paper
• Bacteriophage therapy inspired new age technologies to control antimicrobial resistance

  2025cites this paper
• Phagenendolysine – eine neue Wirkstoffklasse mit vielfältigen Einsatzmöglichkeiten

  2025cites this paper
• A Century of Bacteriophages: Insights, Applications, and Current Utilization

  2025cites this paper
• Assessing the role of zinc in the structure-stability-activity paradigm of bacteriophage T7 endolysin.

  2025cites this paper
• A Novel Truncated CHAP Modular Endolysin, CHAPSAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection

  2024cites this paper
• Prediction of key amino acids of Salmonella phage endolysin LysST-3 and detection of its mutants’ activity

  2024cites this paper
• Ganga River Bacteriophages: Navigating The Biotechnological Landscape For Future Applications

  2024cites this paper
• Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and Recent Applications

  2024cites this paper
• Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy

  2024cites this paper
• A novel truncated CHAP modular endolysin, CHAPSAP26-161, that lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile

  2024cites this paper
• Bacteriophages

  2024cites this paper
• Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae

  2024cites this paper
• Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens

  2024cites this paper
• The food application of a novel Staphylococcus aureus bacteriophage vB_SA_STAP152 and its endolysin LysP152 with high enzymatic activity under cold temperature.

  2024cites this paper
• Characterization and application of LysSGF2 and HolSGF2 as potential biocontrol agents against planktonic and biofilm cells of common pathogenic bacteria.

  2024cites this paper
• Phages for treatment of Salmonella spp infection.

  2023cites this paper
• Characterization and genomic analysis of a broad-spectrum lytic phage HZ2201 and its antibiofilm efficacy against Pseudomonas aeruginosa

  2023cites this paper
• Evaluating the efficacy of endolysins and membrane permeabilizers against Vibrio parahaemolyticus in marine conditions.

  2023cites this paper
• Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

  2023cites this paper
• Bacteriophage Endolysin: A Powerful Weapon to Control Bacterial Biofilms

  2023cites this paper
• Crystal structure of the engineered endolysin mtEC340M.

  2023cites this paper
• Bacteriophages PECP14, PECP20, and their endolysins as effective biocontrol agents for Escherichia coli O157:H7 and other foodborne pathogens.

  2023cites this paper
• Isolation and Characterization of a Weizmannia coagulans Bacteriophage Youna2 and Its Endolysin PlyYouna2

  2023cites this paper
• The therapeutic effect of engineered phage, derived protein and enzymes against superbug bacteria

  2023cites this paper
• New Strategies to Kill Metabolically-Dormant Cells Directly Bypassing the Need for Active Cellular Processes

  2023cites this paper
• Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions.

  2023cites this paper
• Characterization of the LysP2110-HolP2110 Lysis System in Ralstonia solanacearum Phage P2110

  2023cites this paper
• Dietary postbiotics supplementation improves growth, survival rate, antioxidant capacity, non-specific immunity and gut health of juvenile oriental river prawn (Macrobrachium nipponense)

  2023cites this paper
• Chemical-Biology and Metabolomics Studies in Phage-Host Interactions.

  2023cites this paper
• Development of sensitizer peptide-fused endolysin Lys1S-L9P acting against multidrug-resistant gram-negative bacteria

  2023cites this paper
• Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis

  2023cites this paper
• Biological and molecular characterization of fEg-Eco19, a lytic bacteriophage active against an antibiotic-resistant clinical Escherichia coli isolate

  2022cites this paper
• Novel antimicrobial agents for combating antibiotic-resistant bacteria.

  2022cites this paper
• A novel lysin Ply1228 provides efficient protection against Streptococcus suis type 2 infection in a murine bacteremia model.

  2022cites this paper
• Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends

  2022cites this paper
• Thermosensitive Hydrogel Wound Dressing Loaded with Bacteriophage Lysin LysP53

  2022cites this paper
• Inhibition of Listeria monocytogenes by Phage Lytic Enzymes Displayed on Tailored Bionanoparticles

  2022cites this paper
• Expression and biological activity of lytic proteins HolST-3 and LysST-3 of Salmonella phage ST-3.

  2022cites this paper
• Microbial enzymes: the role of enzyme in cancer therapy

  2022cites this paper
• Review of bacteriophage and its applications

  2022cites this paper
• Exploring the therapeutic potential of staphylococcal phage formulations: Current challenges and applications in phage therapy

  2022cites this paper
• Different types of bio preservatives -a comprehensive review

  2022cites this paper
• CBD resistant Salmonella strains are susceptible to epsilon 34 phage tailspike protein

  2022cites this paper
• Successful First Use of a Phage Endolysin for Treatment of Chronic Pelvic Pain Syndrome/Chronic Bacterial Prostatitis

  2022cites this paper
• Antimicrobial Potential of the Genera Geobacillus and Parageobacillus, as Well as Endolysins Biosynthesized by Their Bacteriophages

  2022cites this paper
• Cloning and Characterization of a Thermostable Endolysin of Bacteriophage TP-84 as a Potential Disinfectant and Biofilm-Removing Biological Agent

  2022cites this paper
• Bacteriostatic effects of phage F23s1 and its endolysin on Vibrio parahaemolyticus

  2022cites this paper
• Development of a Novel Chimeric Endolysin, Lys109 With Enhanced Lytic Activity Against Staphylococcus aureus

  2021cites this paper
• Phage-Encoded Endolysins

  2021cites this paper
• Molecular Characterization of Ahp2, a Lytic Bacteriophage of Aeromonas hydrophila

  2021cites this paper
• T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity

  2021cites this paper
• Microbial therapeutic enzymes: A promising area of biopharmaceuticals

  2021cites this paper
• Genomic Analysis of Prophages from Klebsiella pneumoniae Clinical Isolates

  2021cites this paper
• Endolysin, a Promising Solution against Antimicrobial Resistance

  2021cites this paper
• Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application

  2021cites this paper
• Engineered endolysin-based “artilysins” for controlling the gram-negative pathogen Helicobacter pylori

  2021cites this paper
• Phages and their lysins: Toolkits in the battle against foodborne pathogens in the postantibiotic era.

  2021cites this paper
• Genomic characterisation of Lacticaseibacillus paracasei phage ΦT25 and preliminary analysis of its derived endolysin

  2021cites this paper
• Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents.

  2021cites this paper
• Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections.

  2021cites this paper
• Enzybiotics: Endolysins and Bacteriocins

  2021cites this paper
• Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis.

  2021cites this paper
• Fighting Microbes with Microbes

  2020cites this paper
• Antibiotic resistance and persistence—Implications for human health and treatment perspectives

  2020cites this paper
• Lysis of cells of diverse bacteria by l,d‐peptidases of Escherichia coli bacteriophages RB43, RB49 and T5

  2020cites this paper
• DETECTION OF BACTERIOPHAGES AGAINST ESKAPE GROUP OF NOSOCOMIAL PATHOGENS FROM GANGA RIVER WATER DURING COMMUNITY BATH AT VARIOUS RITUALS: SINCE 2013–2019

  2020cites this paper
• Intrinsic resistance of Enterococcus faecalis strains to ΦEf11 phage endolysin is associated with the presence of ΦEf11 prophage

  2020cites this paper
• Characterization of a novel endolysin from bacteriophage infecting Vibrio parahaemolyticus, vB_VpaP_KF2

  2020cites this paper
• Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

  2020cites this paper
• A novel vibriophage exhibits inhibitory activity against host protein synthesis machinery

  2020cites this paper
• Molecular Characterization of a Novel Lytic Enzyme LysC from Clostridium intestinale URNW and Its Antibacterial Activity Mediated by Positively Charged N-Terminal Extension

  2020cites this paper
• The bactericidal efficacy of femtosecond laser-based therapy on the most common infectious bacterial pathogens in chronic wounds: an in vitro study

  2020cites this paper
• An Endolysin LysSE24 by Bacteriophage LPSE1 Confers Specific Bactericidal Activity against Multidrug-Resistant Salmonella Strains

  2020cites this paper
• Identification and in vitro Characterization of a Novel Phage Endolysin that Targets Gram-Negative Bacteria

  2020cites this paper
• Functional characterization of the endolysins derived from mycobacteriophage PDRPxv

  2020cites this paper
• A review of phage mediated antibacterial applications

  2020cites this paper
• Bacteriophage Usage for Bacterial Disease Management and Diagnosis in Plants

  2020cites this paper
• Bacteriophages and Lysins in Biofilm Control

  2020cites this paper
• Recombinant of the Staphylococcal Bacteriophage Lysin CHAPk and Its Elimination against Streptococcus agalactiae Biofilms

  2020cites this paper
• Gram-Negative Bacterial Lysins

  2020cites this paper
• Microbial Diversity, Interventions and Scope

  2020cites this paper
• Cysteine/Histidine-Dependent Amidohydrolase/Peptidase (CHAP)-Displayed Nano Phages: Antimicrobial Function against Methicillin-Resistant Staphylococcus aureus (MRSA)

  2020cites this paper
• Antibacterial proteins and peptides as potential treatment in aquaculture: current status and perspectives on delivery

  2020cites this paper
• A Look at Phage Therapy One Hundred Years After the Bacteriophages Discovery

  2019cites this paper
• Humoral Immune Response to Phage-Based Therapeutics

  2019cites this paper
• Isolation of Escherichia coli Specific Lytic Phages from Wastewater and

  2019cites this paper
• Looking at phage therapy 100 years after the discovery of bacteriophages

  2019cites this paper
• The algal chloroplast as a platform for synthesis of lytic enzymes targeting Gram-negative pathogens

  2019cites this paper
• Downstream Processing of Chlamydomonas reinhardtii TN72 for Recombinant Protein Recovery

  2019cites this paper
• Antibiofilm Enzymes as an Emerging Technology for Food Quality and Safety

  2019cites this paper
• Efficacy and potential of phage therapy against multidrug resistant Shigella spp.

  2019cites this paper